Search for persons
X
?
1
Do Stronger IPR Incentivize Female Participation in Innovat..
NBER working paper series, no. w32547
?
2
Pediatric Drug Adherence and Parental Attention: Evidence f..
NBER working paper series, no. w30968
?
3
Market Size and Research: Evidence from the Pharmaceutical ..
NBER working paper series, no. w28858
?
4
Research and Market Structure: Evidence from an Antibiotic-..
NBER working paper series, no. w28840
?
5
The Role of Assets In Place: Loss of Market Exclusivity and..
NBER working paper series, no. w27588
?
6
Moving Beyond the Valley of Death: Regulation and Venture C..
NBER working paper series, no. w25202
?
7
Unpacking the effects of adverse regulatory events: Evidenc..
NBER working paper series, no. w24957
?
8
Accounting for Price Endogeneity in Airline Itinerary Choic..
NBER working paper series, no. w22730
?
9
Corporate Venture Capital as a Real Option in the Markets f..
NBER working paper series, no. w21424
?
10
Assets with "Warts": How Reliable is the Market for Technol..
NBER working paper series, no. w21103
?
11
Generic Competition and the Incentives for Early-Stage Phar..
NBER working paper series, no. w20532
?
12
The Direct and Indirect Effects of Small Business Administr..
NBER working paper series, no. w20543
?
14
Explaining Preferences for Control Rights in Strategic Alli..
NBER working paper series, no. w18364
?
15
Regulation and Welfare: Evidence from Paragraph IV Generic ..
NBER working paper series, no. w17188